MRD / Regn No. : 20250000727 Date : 24/07/2026
Patient Name : Riti Venkateshan Naranappa Age & Gender : 14 Yrs. / Female
Contact No. : 9629103897 UHID :
Ht / Wt / BMI : 157 / 55.9 / 22.68 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : DIABETES MELLITUS (01/Jun/2025) | MODY 1 (16/Oct/2025) | MODY (16/Oct/2025) |
Subjective : MODY,RESULT REVIEW,PATIENT N/A,MPA WITHDRAWAL
Objective : NONE
Analysis : MILD PROLACTIN ELEVATION,DIABETES MELLITUS,LOW HSCRP,MODY1,HYPOTHYROIDISM
Plan : INCREASE GLIBENCLAMIDE TO 2.5 MG PER DAY,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 78 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 144 mg/dL | FREE T3: 2,7 ng/dL | FREE T4 : 1.9 ng/dL | TSH : 2.1 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET GLIBENCLAMIDE 1.25 MG
GLYBOVIN
Medicine For MODY1
PO 1-0-1 30 MINS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE LOW SUGARS
2 TABLET THYROXINE 75 MCG
THYRONORM 75 MCG
Medicine For HYPOTHYROIDISM
PO 1-0-0 EMPTY STOMACH
TILL NEXT VISIT
MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Sep/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: